309778
Regional and Gender Differences in HIV Testing when Risk Factors Are Present: Evidence from the 2012 BRFSS
Methods: We identified 10,309 (weighted estimate: 86,543) individuals, >=18 years old who responded ‘yes’ to the BRFSS question (q18.3) on known HIV risk factors. We computed weighted estimates of those who tested for HIV and measured their association with region, gender and potential confounders. Multiple logistic regression (MLR) generated odds ratios for HIV testing after controlling for confounders. Results: The sample mean age was 64.2 (SD.14.9), 54% male; 51.5% White, 18.9% Black or African American. Approximately 62% had voluntarily tested for HIV. HIV testing was associated with region of residence and gender (p<0.001). MLR showed that compared to the Northeast, respondents from the Midwest (OR: 0.51: 95%CI: 0.40 - 0.65, p =0.001) and West (OR: 0.73: 95%CI: 0.57 – 0.93, p= 0.001) had significantly lower odds of getting tested for HIV. Women had 1.5 times greater odds of HIV testing than men (OR: 1.57; 95% CI: 1.33 -1.85, p=0.001). Conclusion: HIV/AIDS prevention outreach strategies stressing the benefits of early testing and treatment should focus on populations most at risk.
Learning Areas:
Planning of health education strategies, interventions, and programsProtection of the public in relation to communicable diseases including prevention or control
Learning Objectives:
Describe gender differences in voluntary HIV testing
Describe regional variations in gender differences in voluntary HIV testing
Describe correlates of HIV testing among persons with risk factors
Keyword(s): HIV Risk Behavior, Risk Factors/Assesment
Organization/institution whose products or services will be discussed: N/A
Qualified on the content I am responsible for because: I am a graduate student of public health conducting research in infectious disease under working with my professor.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.